Engineered factor IX variants bypass FVIII and correct hemophilia A phenotype in mice.
about
Gene therapy for hemophiliaTissue Concentrations of Vitamin K and Expression of Key Enzymes of Vitamin K Metabolism Are Influenced by Sex and Diet but Not Housing in C57Bl6 Mice.Improved hemostasis in hemophilia mice by means of an engineered factor Va mutantEngineering Factor Viii for Hemophilia Gene Therapy.Galectin-9 is a suppressor of T and B cells and predicts the immune modulatory potential of mesenchymal stromal cell preparationsBlood Clotting Factor VIII: From Evolution to Therapy.Novel therapeutic approaches for haemophilia.Muscle Gene Therapy for Hemophilia.Rate-limiting roles of the tenase complex of factors VIII and IX in platelet procoagulant activity and formation of platelet-fibrin thrombi under flow.Next generation FIX muteins with FVIII-independent activity for alternative treatment of hemophilia A.Oral gene therapy for hemophilia B using chitosan-formulated FIX mutants.Coagulation Factor IX for Hemophilia B Therapy.A quantitative and humane tail bleeding assay for efficacy evaluation of antihaemophilic factors in haemophilia A mice.Hierarchical organization of the hemostatic response to penetrating injuries in the mouse macrovasculature.
P2860
Q28081911-FDD7B672-277B-49C7-B600-6F4EA32A8DABQ33468356-697878C8-2DA6-4E04-BBC8-86062BC7A7C6Q34165592-454FD362-F952-4882-B30A-AF32BF4BAA0EQ36737263-F4AB0984-6519-4E57-9A1A-8AF39A6BB0C6Q37667547-01B229D3-00B2-4B89-9BF1-AB6E054C5E74Q38118763-595BA4B8-FA33-4048-AA9E-392C6A39912BQ38293116-554F538A-F471-43A5-BED2-F7BA43C1648BQ40055959-D6C8961E-639E-48F5-A29E-FAF3552AF3F5Q41226859-B92F8BB5-C43A-4301-82C5-173C6A3F7B23Q42187640-F0C474F7-1BCF-4FC4-A2C0-F9398B56069DQ42228305-A1C2E6E8-D3F1-44B8-9BB9-C9E6BD10BDB5Q42256024-ECE20FAF-59C2-478C-8471-7C783C255949Q45866451-F195912D-6E5B-4787-BE53-5A041ABFD00EQ51001918-D0A98B77-5A1B-463C-8C2E-E3069AA77BBC
P2860
Engineered factor IX variants bypass FVIII and correct hemophilia A phenotype in mice.
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Engineered factor IX variants bypass FVIII and correct hemophilia A phenotype in mice.
@ast
Engineered factor IX variants bypass FVIII and correct hemophilia A phenotype in mice.
@en
Engineered factor IX variants bypass FVIII and correct hemophilia A phenotype in mice.
@nl
type
label
Engineered factor IX variants bypass FVIII and correct hemophilia A phenotype in mice.
@ast
Engineered factor IX variants bypass FVIII and correct hemophilia A phenotype in mice.
@en
Engineered factor IX variants bypass FVIII and correct hemophilia A phenotype in mice.
@nl
prefLabel
Engineered factor IX variants bypass FVIII and correct hemophilia A phenotype in mice.
@ast
Engineered factor IX variants bypass FVIII and correct hemophilia A phenotype in mice.
@en
Engineered factor IX variants bypass FVIII and correct hemophilia A phenotype in mice.
@nl
P2093
P921
P1433
P1476
Engineered factor IX variants bypass FVIII and correct hemophilia A phenotype in mice.
@en
P2093
Daniela Abriss
Erhard Seifried
Jörg Schüttrumpf
Lacramioara Ivanciu
Manuel Grez
Patricia Quade-Lyssy
Peter Milanov
Sonja Alesci
Torsten Tonn
Wolfgang Miesbach
P304
P356
10.1182/BLOOD-2011-05-353672
P407
P577
2011-10-26T00:00:00Z